Corpus luteum and fetoplacental functions in monkeys hypophysectomized during late pregnancy

The hormonal regulation of corpus luteum (CL) function during late pregnancy was studied in hypophysectomized monkeys. Between days 149-154 of gestation, 9 days after hypophysectomy, progesterone in the uteroovarian vein (UOV), uterine vein (UV) and peripheral circulation (P) averaged 179.7 ng/ml, 38.9 ng/ml and 5.5 ng/ml, respectively. Amniotic fluid prolactin ranged from 2150-6700 ng/ml and monkey chorionic somatomammotropin (mCS) in mothers carrying live fetuses ranged from 11.4-30.8 micrograms/ml in the UV and P. Prolactin and monkey chorionic gonadotropin in the UV and P were low or nondetectable as was mCS in 2 mothers carrying dead fetuses. CL function was further studied 7 and 39 days after removal of the fetus alone or both the fetus and placenta. Placental delivery was extremely variable, ranging from 2-greater than 63 days post-fetectomy. Although progesterone was not detectable in the P7 days after cesarean section in those animals in which both fetus and placenta were absent, surprisingly, progesterone was measurable in the UOV (range 1.6-48.2 ng/ml). At 39 days, progesterone was either nondetectable or very low. We have interpreted these data to mean: 1) neither the maternal pituitary gland nor a live fetus is necessary for placental or corpus luteum production of progesterone during late pregnancy, 2) the presence of high levels of circulating prolactin and mCS are apparently not necessary for continued secretion of progesterone from the CL during late pregnancy, 3) the fetoplacental unit may be the source of the luteotropic stimulus of late pregnancy since progesterone in the UOV decreases markedly in the absence of the fetoplacental unit or disruption of the unit brought about by fetectomy, and 4) regression of the CL following cesarean section in hypophysectomized monkeys is exceedingly slow when compared to the precipitous regression characteristic of the CL of the nonfertile menstrual cycle.

Chorionic gonadotropin, chorionic somatomammotropin, and prolactin in the uterine vein and peripheral plasma of pregnant rhesus monkeys

Seven adult female rhesus monkeys were laparotomized at days 22, 42, and 157 of pregnancy and blood was collected from the uterine vein and peripheral circulation. Plasma samples were analyzed for monkey chorionic gonadotropin (mCG), monkey chorionic somatomammotropin (mCS), and prolactin by radioimmunoassay. Levels of mCG at day 22 of pregnancy were approximately 250 ng/ml; however, during the later stages of gestation mCG was either nondetectable or less than 0.7 ng/ml. There was no statistical difference in prolactin concentrations between days 22 and 42 of pregnancy, mean levels being between 176-424 ng/ml, but by day 157 prolactin levels of greater than 2,000 ng/ml were recorded. No statistical difference existed between peripheral and uterine vein concentrations of either mCG or prolactin at any of the stages of gestation examined. At day 22, mCS was not detectable; however, at day 42 of gestation mCS titers averaged 1.5 micrograms/ml and 2.3 micrograms/ml in the peripheral and uterine vein plasma, respectively. A statistically significant mCS increase occurred by day 157, levels in the periphery and uterine vein averaging 11.0 micrograms/ml and 16.3 micrograms/ml, respectively. Uterine vein titers of mCS were significantly higher than peripheral titers at both days 42 and 157. Thus, the highest levels of mCG were present during early pregnancy, whereas the highest levels of mCS and prolactin were present during late pregnancy.

Cholesterol side chain cleavage and aromatase activities in the corpus luteum of the pregnant rhesus monkey

Cholesterol side-chain cleavage (CSCC) and aromatase activities were measured in luteal mitochondria and tissue pieces, respectively, from rhesus monkeys on days 22, 49, 128 and 160 of gestation. CSCC activity did not vary significantly during gestation and thus probably does not respond to chorionic gonadotropin which is elevated on day 22 of pregnancy. It is not known, however, whether CSCC can be stimulated prior to day 22 when the corpus luteum is steroidogenically more active. Both 3H-pregnenolone and 3H-progesterone were synthesized from [1,2-3/]cholesterol. Aromatase activity declined from high levels on days 22 and 49 to a nadir on day 128 of pregnancy. Utilizing either [1beta-3H]androstenedione or [1beta-3H]testosterone as substrate yielded comparable results throughout gestation.

Placental and luteal steroidogenesis in the pregnant rhesus monkey

Progesterone, 20alpha-dihydroprogesterone, estrone and estradiol-17beta concentrations were estimated by radioimmunoassay in blood plasma from uterine, uteroovarian and femoral veins of rhesus monkeys (Macaca mulatta) on days 22, 49, 128 and 160 of gestation. Steroids were consistently more concentrated in uterine and uteroovarian that in femoral venous plasma and in many cases levels in the uteroovarian vein were also higher than those in the uterine vein indicating luteal secretion of both progestins and estrogens thoughout gestation. In some animals, however, the corpus luteum appeared quiescent. As reflected in the decline in the uterine venous progesterone/estradiol-17beta concentration ratio, a shift in steroid contribution from the uterus and its contents occurred between days 22 and 49 of gestation with progesterone declining more rapidly than estradiol-17beta. Progesterone/20alpha-dihydroprogesterone was higher in both uterine and uteroovarian than in femoral venous plasma suggesting peripheral metabolism of progesterone to 20alpha-dihydroprogesterone.

Recovery from lethal x-ray damage during delayed implantation in the rat

Rats were exposed to either 300 or 500 röntgen (R) acute whole-body X-irradiation on the 5th day of delayed pregnancy induced by ovariectomy. From 0 to 8 days after irradiation, implantation was induced by the administration of oestrogen. Foetal survival to the 20th day of development was used as an index of radiation effect.

If oestrogen was given immediately after exposure to 300 R, or 12 h later, only 30–35% of the embryos survived, significantly less (P < 0·01) than the non-irradiated control values of 74–79%. When implantation was postponed for 24 h or more, embryonic survival ranged from 57 to 64% and was not significantly different from that of controls.

After exposure to 500 R X-irradiation, embryonic survival increased linearly from 2% to a maximum of 41% as the interval between irradiation and oestrogen administration increased from 0 to 48 h. Embryonic survival never reached control levels after 500 R, regardless of the interval between irradiation and implantation. The irradiation regimens also induced developmental abnormalities, doubled the incidence of dead foetuses (death at a late stage of development), and significantly reduced foetal and placental weights at autopsy.

The results confirm that recovery from potentially lethal X-irradiation damage can occur during delayed implantation, and demonstrate that both the extent and the rate of recovery are functions of the radiation dose.